Differentiated thyroid carcinoma : treatment and clinical consequences of therapy

Author(s):
Hoftijzer, H.C.
Published
2011
Publication type
Doctoral Thesis

Abstract

The first chapters of this thesis describe the treatment of radioiodine non-avid thyroid carcinoma with the tyrosine kinase inhibitor sorafenib. The remainder of the thesis describes the clinical consequences of the treatment of thyroid carcinoma.

Differentiated thyroid carcinomaDiagnosisTreatmentThyroid hormone metabolism
Defense date
2011-05-12
Language
English
Supervisor(s)
Smit, J.W.A.; Romijn, J.A.
Advisor(s)
Kleij-Corssmit, E.P.M. van der
Qualification
Ph.D.
Degree granting institution
Leiden University Medical Center (LUMC), Leiden University, Leiden
hdl
1887/17641
ISBN(s)
9789461690326

Funding

Sponsorship
Bayer B.V. Novo Nordisk B.V. Servier Nederland Farma B.V. MSD B.V. Genzyme B.V. AstraZeneca B.V. Ipsen Farmaceutica B.V. Novartis Pharma B.V. J.E. Jurriaanse Stichting